Possible steps of complete disassembly of post-termination complex by yeast eEF3 deduced from inhibition by translocation inhibitors. by Kurata, Shinya et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Biochemistry and Molecular Biology
Faculty Papers Department of Biochemistry and Molecular Biology
1-1-2013
Possible steps of complete disassembly of post-
termination complex by yeast eEF3 deduced from
inhibition by translocation inhibitors.
Shinya Kurata
Thomas Jefferson University, kurasan0623@gmail.com
Ben Shen
Scripps Florida, Jupiter, FL, shenb@scripps.edu
Jun O Liu
Johns Hopkins University, joliu@jhu.edu
Nono Takeuchi
The University of Tokyo
Akira Kaji
University of Pennsylvania, kaji@mail.med.upenn.edu
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/bmpfp
Part of the Medical Biochemistry Commons, and the Medical Pharmacology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Biochemistry and Molecular Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Kurata, Shinya; Shen, Ben; Liu, Jun O; Takeuchi, Nono; Kaji, Akira; and Kaji, Hideko, "Possible
steps of complete disassembly of post-termination complex by yeast eEF3 deduced from inhibition
by translocation inhibitors." (2013). Department of Biochemistry and Molecular Biology Faculty Papers.
Paper 43.
http://jdc.jefferson.edu/bmpfp/43
Authors
Shinya Kurata, Ben Shen, Jun O Liu, Nono Takeuchi, Akira Kaji, and Hideko Kaji
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/bmpfp/43
Possible steps of complete disassembly of
post-termination complex by yeast eEF3 deduced
from inhibition by translocation inhibitors
Shinya Kurata1, Ben Shen2,3, Jun O. Liu4, Nono Takeuchi5, Akira Kaji6 and
Hideko Kaji1,*
1Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University,
Philadelphia, PA 19107, 2Department of Chemistry, 3Department of Molecular Therapeutics, The Scripps
Research Institute, Jupiter, FL 33458, 4Department of Pharmacology and Molecular Sciences, School of
Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA, 5Department of Medical Genome
Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba 277-8562, Japan and
6Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Received June 15, 2012; Accepted September 21, 2012
ABSTRACT
Ribosomes, after one round of translation, must be
recycled so that the next round of translation can
occur. Complete disassembly of post-termination
ribosomal complex (PoTC) in yeast for the recycling
consists of three reactions: release of tRNA, release
of mRNA and splitting of ribosomes, catalyzed by
eukaryotic elongation factor 3 (eEF3) and ATP.
Here, we show that translocation inhibitors cyclohe-
ximide and lactimidomycin inhibited all three reac-
tions. Cycloheximide is a non-competitive inhibitor
of both eEF3 and ATP. The inhibition was observed
regardless of the way PoTC was prepared with
either release factors or puromycin. Paromomycin
not only inhibited all three reactions but also
re-associated yeast ribosomal subunits. On the
other hand, sordarin or fusidic acid, when applied
together with eEF2/GTP, specifically inhibited ribo-
some splitting without blocking of tRNA/mRNA
release. From these inhibitor studies, we propose
that, in accordance with eEF3’s known function in
elongation, the release of tRNA via exit site occurs
first, then mRNA is released, followed by the split-
ting of ribosomes during the disassembly of post-
termination complexes catalyzed by eEF3 and ATP.
INTRODUCTION
Protein synthesis consists of four phases: initiation,
elongation, termination and ribosome recycling (1).
The elongation phase involves the movement of tRNA
(translocation) through the three tRNA-binding sites (A,
P and E sites corresponding to aminoacyl, peptidyl and
exit sites, respectively) on the ribosome. Translocation by
eukaryotic elongation factor 2 (eEF2) and GTP shifts the
peptidyl-tRNA from the A site to the P site and the
deacylated tRNA from the P to the E site. The eukaryotic
translocation step is widely accepted as the speciﬁc target
of cycloheximide (CHX) and related compounds such as
lactimidomycin (LTM) (2). In yeast and other fungi, in
addition to eEF2 and eEF1A, eEF3 is believed to be
essential for the peptide elongation step (3) and is indis-
pensable for yeast (4). eEF3 has been shown to facilitate
the exchange of labelled E-site-bound tRNA with added
deacylated tRNA and cause the release of the E-site-
bound tRNA upon addition of eEF1A/GTP/aminoacyl-
tRNA (5). Furthermore, eEF3 interacts with eEF1A (6).
For the termination step, the release factor eRF1, bound
at the A-site with the termination codon, hydrolyzes the
peptidyl-tRNA ester bond with the help of eRF3 and
GTP, forming the post-termination complex (PoTC)
(7,8). The ribosome of PoTC needs to be recycled to
initiate the next round of translation.
As originally the term was coined (9), ‘ribosome
recycling’ was meant to represent the reaction to recycle
the spent ribosome for the next round of translation of
new mRNA. We deﬁne this reaction as disassembly of
PoTC involving release of mRNA and tRNA from the
ribosome accompanied by splitting of the ribosome into
subunits. In yeast, we reported that ribosome recycling is
catalysed by eEF3/ATP. The reaction is inhibited by
aminoglycosides such as neomycin and hygromycin. It is
clearly energy-dependent because a non-hydrolysable
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analogue of ATP did not replace ATP (10). In this system,
PoTC was created from puromycin-treated polysomes
assuming that the behaviour of ribosomes in the naturally
occurring PoTC is identical to that of this model PoTC. In
addition to this system, ABCE1 (Rli1 in yeast) and ATP
have been reported to catalyse the splitting of yeast PoTC
into mRNA/40S subunit complex [Figure 5A of (11)].
Although the scheme they presented indicates that
tRNA is released (step 6 of Figure 7 of their article), no
data for the tRNA release were presented (11). In their
experiment, PoTC with three-codon ORF containing
tRNAPhe at the P-site and UAA at the A-site was used.
Despite the fact that there has not been any description of
yeast factors responsible for the release of mRNA and
tRNA from the complex of 40S subunits formed by
Rli1, we assume that the complete disassembly of PoTC
occurs after the action of Rli1 by some unknown means.
Available data will be dealt with in the discussion section
regarding the possibility that yeast Rli1 and eEF3 function
in the ribosome recycling in vivo.
ABCE1 is also suggested to be involved in Archaea
ribosome recycling on the basis of its ribosome splitting
activity of the mRNA/ribosome complex [Figure 4 of
(12)]. Possible structural basis of this action was presented
using crystal structure of ABCE1. However, it is not clear
whether ABCE1 is acting on the PoTC or some other
ribosomal complex in their system. Although no data on
the release of tRNA or mRNA were presented, their
scheme (Figure 6 of their article) indicates that both
mRNA and tRNA are still on the subunits after splitting
of ribosomes by ABCE1, suggesting that additional steps
must take place to complete ribosome recycling (12). As
for higher eukaryotes, ABCE1 splits rabbit reticulocytes
PoTC leaving mRNA and tRNA on the 40S subunits (13).
An additional factor called Ligatin (14) or a combination
of initiation factors eIF3/eIF1/eIF1A/eIF3j (13) is
required to remove mRNA and tRNA to complete the
disassembly of PoTC. In addition to these ABCE1/
Ligatin and ABCE1/eIF3/eIF1/eIF1A/eIF3j pathways,
an earlier report suggested that eIF3, eIF1, eIF1A and
eIF3j, without ABCE1, disassemble PoTC in 2.5mM
MgCl2/1mM GTP (15). This was conﬁrmed in
nucleotide-unbound MgCl2 concentration of 1mM and
1mM ATP/0.4mM GTP (13). It is unlikely that Ligatin
(called Tma64 in yeast) is involved in yeast ribosome
recycling because Tma64 is not essential for yeast (16)
while the ribosome recycling is an essential step for life (9).
In this article, as reported previously, we deal with the
case where the components of PoTC including mRNA
and tRNA are completely released from the complex by
eEF3 and ATP. The time course of the complete disassem-
bly measured by the conventional method suggested that
the three reactions—tRNA release, mRNA release and
ribosome splitting—may take place almost simultan-
eously. However, we show here that CHX, LTM,
paromomycin (PAR), eEF2/GTP/sordarin (SOR) and
eEF2/GTP/fusidic acid (FA) inhibit the eEF3-dependent
recycling of PoTC in a fashion that suggests that the dis-
assembly begins with tRNA release followed by the release
of mRNA, then the splitting of ribosomes.
MATERIALS AND METHODS
Buffers
Buffer X/Y contains 20mM Hepes-KOH (pH 7.6), X mM
MgCl2, Y mM KCl and 2mM DTT.
Preparation of PoTC polysome, elongation factors,
termination factors and 32P-labelled 60S subunits
The polysomes consisting of model PoTC strung together
with mRNA were prepared as described (10). Brieﬂy,
Saccharomyces cerevisiae strain WY344 was grown at
30C in 4.8 l of yeast extract/peptone/dextrose medium
with shaking (190 rpm) for 1–1.5 days, until the culture
reached a density of OD600=1.6. Cells were immediately
cooled by the addition of crushed ice and were centrifuged
at 3000g for 10min at 4C. One cell volume (about 12ml)
of buffer 10/50 containing 250mM sucrose, 0.2mg/ml
heparin and 0.2mM PMSF was added together with
12 ml of acid-washed glass beads (Sigma, 425–600mm).
The cells were disrupted by vortexing ﬁve times for 30 s
with 1-min breaks on ice between each vortexing. The
disrupted cells were centrifuged as above to remove
intact cells and glass beads. The supernatant was
re-centrifuged at 17 000g for 10min at 4C to remove
debris, and the lysate obtained (15ml containing the poly-
somes) was adjusted to high salt buffer 25/500 and left
standing for 5min on ice. This process stops movement
of ribosomes on the mRNA. The extract was then sub-
jected to sucrose density gradient centrifugation (SDGC),
and the fractions containing only polysomes were col-
lected. The high-salt wash removes most of the
non-ribosomal proteins and the E-site-bound tRNA
(17). Run-off ribosomes that might have been produced
during the above process were removed by this procedure.
Thus, in the experiments, polysome run-off can be avoided
in the absence of CHX. The polysomes were incubated
with eEF2 and GTP to translocate peptidyl-tRNA from
the A to the P site, followed by a second high-salt wash to
remove added eEF2 and E-site-bound tRNA. Puromycin
(PUR) was then added to make model PoTC. The model
PoTC consists of a ribosome with tRNA on the P-site and
any triplet on the A-site. Each model PoTC is strung
together with mRNA thus keeping the form of a
polysome. Elongation factors were prepared as described
(10).
32P-labelled 60S subunits were prepared as described
(15) using casein kinase (18). Brieﬂy, 0.56 mM 60S
subunits were prepared as described (19) and were
phosphorylated with 500U/ml casein kinase II (New
England BioLabs) and 50 mCi of [g-32P]ATP (6000Ci/
mmol, Perkin Elmer) in 110 ml of the reaction mixture
containing buffer 10/50 for 30min at 30C. The mixture
was loaded onto 4.5 ml of 5–30% (w/v) sucrose gradient
prepared in buffer 5/50 and sedimented for 7 h at 4C
(Beckman SW50.1 rotor, 49 000g). The sedimentation be-
haviour was monitored using an ISCO UA-6 spectropho-
tometer at 254 nm, and the fractions containing the
[32P]60S subunits (2 4 104 dpm/pmol) were pooled
(0.6 ml) and stored at 80C. Termination factors were
prepared as described in the Supplementary Methods.
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Disassembly of the PoTC
The complete disassembly of the PoTC was analysed as
previously described (10) with some modiﬁcations detailed
below. To detect the release of tRNA from the PoTC
(Figure 1G, 4A, 5A and Table 1), polysomes (3 A260
units) were disassembled in buffer 3/150 (600ml) with
1mM PUR, 50 mM ATP (potassium salt) and 0.5 mM
eEF3. The reaction mixture was ﬁltered through a
Millipore ﬁlter, and tRNA, which had been released
from the ribosomes, was measured in the ﬁltrate by
charging it with a mixture of [14C]amino acids and
aminoacyl-tRNA synthetases. To detect the release of
mRNA from the PoTC (Figure 1A–C and H, 2, 4B and
5B), polysomes (0.75 A260 units, 15 pmol) were
disassembled in buffer 3/150 (150ml) by the addition of
PUR, ATP and eEF3 as described above. The reaction
was stopped by the addition of MgCl2 to 25mM. The
mixture was loaded onto 4.5ml of 15–45% sucrose
gradient prepared in buffer 25/150 and sedimented for
75min at 4C (Beckman SW50.1 rotor, 150 000g). To
detect the ribosome splitting of the PoTC (Figure 1D–F
and I, 4C, 5C–D and 7), the disassembly reaction was
performed in the same way as the mRNA release assay
and stopped by 4% (v/v) formaldehyde. The mixture was
loaded onto 4.5 ml of 5–30% sucrose gradient prepared in
buffer 3/150 and sedimented for 128min at 4C (SW50.1
rotor, 150 000g). The sedimentation behaviour of poly-
somes and the ribosomes was monitored using an ISCO
UA-6 spectrophotometer at 254 nm. In all experiments,
inhibitors were added at time zero, and the reaction was
allowed to proceed for 1min. The percent inhibition was
calculated from the extent of the reaction with each con-
centration of inhibitors compared with that without
antibiotic.
In Figure 3B and C, the disassembly of PoTC prepared
with eRF1 and eRF3 was performed and the effect of
CHX was studied. For this experiment, the puriﬁed poly-
somes (15 pmol) were incubated in 45 ml buffer 5/50 with
0.75mM eRF1, 0.75mM eRF3 and 0.33mM GTP for
30min at 30C. Next, MgCl2, KCl, Hepes-KOH (pH
7.5), DTT and water were added to the reaction mixture
so that it was in 150 ml buffer 3/150. Then, 0.5 mM eEF3
and 50 mM ATP were added to the reaction mixture,
followed by 3-min incubation at 30C. The reaction was
stopped by the addition of 25mMMgCl2 and analyzed by
15–45% SDGC (SW50.1 rotor, 150 000g, 75min at 4C) in
buffer 25/150. In Figure 3C, various concentrations of
CHX were added at time zero, and the disassembly of
PoTC prepared with eRF1 and eRF3 was allowed to
run for 1min.
To verify that the predominant 80S ribosomes observed
in Figure 7 in the presence of SOR or FA were indeed
derived from polysomes (PoTCs strung together
with mRNA), we conducted an experiment shown in
Figure 8A–E. In this experiment, the disassembly of the
PoTC was carried out for 1min as described above for the
mRNA release assay in the presence or absence of 0.5 mM
eEF2, 10 mM GTP and 100 mM SOR or 1mM FA. The
reaction was stopped by 4% formaldehyde, and the disas-
sembly was measured by subjecting the reaction mixture
to 15–50% SDGC (SW50.1 rotor, 150 000g, 90min at
4C) in buffer 3/150.
In Figure 8F and G, the disassembly reaction was
carried out in the presence of 32P-labelled 60S subunits
(2 4 104 dpm/pmol) and eEF2/GTP/SOR or FA as
described above. The reaction was stopped by 4% formal-
dehyde. The mixture was subjected to 5–30% SDGC
(SW50.1 rotor for 128min at 150 000g), and both the
UV absorbance and radioactivity of each fraction were
measured.
Peptide release assay
To establish the hydrolysis of ribosome-bound peptidyl-
tRNA by eRF1 and eRF3 in the absence of a termination
codon at the A-site, we prepared 35S-labelled peptidyl-
tRNA bound to the polysomes as described below. The
yeast lysates (4.8ml) prepared as described above were
incubated with 25.2 nM [35S]methionine (1.175Ci/mmol,
Perkin Elmer), 1mM ATP, 0.5mM GTP, 20mM
creatine phosphate and 40 mg/ml creatine kinase in
buffer 3/150 for 10min at 30C to label the nascent
peptides. After the incubation, MgCl2, KCl, Hepes-
KOH (pH 7.5), DTT and water were added so that the
reaction mixture was in buffer 25/500. The labelled poly-
somes (9.3 ml) were subjected to SDGC (6 ml of 15–45%
sucrose gradient layered on 1.13 ml of 80% sucrose
cushion prepared in buffer 10/50) for 5 h at 37 500 rpm
(174 000g) in Beckman rotor SW41. The isolated poly-
somes (4.4 nmol) were then translocated with 14 nmol of
eEF2 in 7ml of buffer 5.5/150 containing 1.4mmol of
GTP. The translocated labelled polysomes were again sub-
jected to SDGC (as described above) to further purify the
polysomes.
35S-labelled polysomes thus prepared (20 pmol, contain-
ing [35S]peptidyl-tRNA (113 cpm/pmol) at the P-site) were
incubated as shown in Figure 3A in 60 ml buffer 5/50 with
0.5 mM eRF1, 0.5 mM eRF3 and 0.33mM GTP at 30C.
The reaction was stopped by 1mM anisomycin (20),
followed by the addition of MgCl2 to 25mM to stabilize
the complex. The mixture was loaded onto 4.5ml of
15–45% sucrose gradient prepared in buffer 25/50 and
sedimented for 75min at 4C (SW50.1 rotor, 150 000g).
The fractions containing polysomes were manually col-
lected, and cold trichloroacetic acid (5%) insoluble
radioactivity of the polysomes was counted. Decrease
of polysome-associated radioactivity was regarded as
hydrolysis of peptidyl-tRNA by eRF1 and eRF3.
ATP hydrolysis assay
In the ATPase experiment shown in Figure 6, a standard
reaction mixture (15 ml) contained 0.1 mM polysomes,
0.5 mM eEF3, 1mM PUR and 50 mM [g-32P]ATP
(speciﬁc activity 1.32mCi/mmol), as well as various con-
centrations of an inhibitor in 3/150 buffer. Incubation was
carried out at 30C for 1min. The release of inorganic
phosphate from [g-32P]ATP upon hydrolysis was analysed
by monitoring ammonium molybdate-soluble radioactiv-
ity as described (21) except that the reaction volumes were
reduced by 25%.
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Figure 1. Inhibitory effect of CHX on the disassembly of the PoTC by eEF3/ATP. (A–C) CHX inhibits the release of mRNA from PoTC.
Sedimentation proﬁles of polysomes after the disassembly reaction of PoTC by eEF3/ATP under various conditions are shown. Final concentrations
of each component are as follows: 50 mM ATP, 0.5 mM eEF3, 1mM PUR, 360mM CHX. The standard reactions for the disassembly of PoTC were
stopped by buffer 25/150. This buffer converts the formed subunits to 80S ribosomes. The mixtures were subjected to SDGC with 150 000g for
75min. (A) Only ATP/PUR was added. (B) Complete reaction mixture. (C) B in the presence of 360 mM CHX. Incubation was for 1min at 30C.
The decrease of polysome area is accompanied by increase of the 80S ribosome (the arrows). Numbers on top of the polysome region indicate the
percentage decrease of the area under each experimental condition. Note that in (C) (in the presence of CHX) the decrease of PoTC is signiﬁcantly
lower (43% versus 7%), and the increase of 80S ribosomes is less. (D–F) CHX inhibits the ribosome splitting of PoTC. For D–F, the reaction
mixtures were ﬁxed by formaldehyde to preserve subunits formed during the disassembly (10). They were centrifuged for 128min at 150 000g to
observe subunits. Remaining PoTC was pelleted and not observed under these sedimentation conditions. (D) Polysomes with ATP and PUR.
(E) Complete reaction mixture. (F) E in the presence of 360 mM CHX. Note that subunits (arrows) were much less in F than E, indicating that
the splitting of PoTC is inhibited by CHX. (G–I) Determination of IC50 of CHX on the three disassembly reactions of the PoTC by eEF3/ATP.
Various amounts of CHX were added just before the disassembly reaction. IC50s of tRNA release (G), mRNA release (H) and the ribosome splitting
(I) are shown.
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RESULTS
CHX inhibits disassembly of the PoTC by eEF3/ATP
Preliminary studies suggested that CHX inhibited eEF3-
dependent release of mRNA from PoTC (10). Here, we
examined the mechanism of the CHX action. In the ex-
periment described in Figure 1, we prepared model PoTC
by removing nascent peptide chains from the peptidyl-
tRNA by PUR on the poly-ribosomes isolated from
growing yeast. Before the puromycin reaction,
peptidyl-tRNA bound at the A-site was translocated to
the P-site by eEF2/GTP. The complex thus prepared
consists of several PoTCs strung together with mRNA
keeping the form of polysome except for the absence of
the nascent peptide. The release of deacylated tRNA from
the PoTC was assayed by charging the released tRNA
with [14C]amino acids (see Materials and Methods). The
release of mRNA from the PoTC was detected by the
decrease of the polysomes and simultaneous appearance
of 80 S ribosomes as shown in Figure 1A–C. The reason
why we observe 80S ribosomes instead of subunits is that
we added Mg2+ at the end of the reaction to convert
subunits to 80S ribosomes for the ease of analysis. It is
clear from these ﬁgures that eEF3 created a large peak
of 80S ribosomes, with the sacriﬁce of polysomes
(Figure 1B). When CHX was added, the conversion was
mostly stopped (Figure 1C). In Figure 1D–F, the addition
of Mg2+ was omitted, and the mixture was sedimented
longer to observe the subunits. There were some
pre-existing subunits (Figure 1D), but the amount of
subunits (Figure 1E, arrows) was signiﬁcantly more when
eEF3 was added. In the presence of CHX, the increase of
subunits was effectively prevented (compare E with F).
Figure 1G–I show the dose–response curves of CHX on
the three reactions of the complete disassembly (tRNA
release, mRNA release and ribosome splitting). The concen-
trations of CHX required to cause 50% inhibition (IC50) of
the three reactions were very similar (3–4mM). Further-
more, those IC50 values were comparable with the IC50
for the inhibition of translocation [1.2mM for CHX (22)],
suggesting that the binding constant of CHX to PoTC is
virtually the same as for binding to elongating ribosomes.
CHX is a non-competitive inhibitor of both eEF3 and ATP
Kinetic analyses show that CHX is a non-competitive
inhibitor of eEF3 (Figure 2A–C). This is because the ribo-
somal binding site of CHX is different from that of eEF3.
Thus, CHX binds to rabbit ribosomes at the site sur-
rounded by 28S rRNA (corresponds to 25S rRNA in
yeast), L27a (yeast L28) and L36a (yeast L42) in the 60S
subunit (2,23), while eEF3 binds to 5S rRNA, L5 and L11
in the 60S subunit as well as the 40S subunit (24). The Ki
and Ki’ values of CHX were about 34 and 33 mM, respect-
ively, indicating that the afﬁnity of CHX is not inﬂuenced
by eEF3. These values are comparable with the Kd value
of CHX with vacant ribosomes (15mM) (2). CHX was also
a non-competitive inhibitor of ATP (Figure 2D–F),
probably because CHX binds to the ribosome while
ATP binds to eEF3 (24).
CHX inhibits disassembly of PoTC created by
eRF1 and eRF3
It has been reported that ABCE1 dissociates the 60S
subunit from rabbit PoTC prepared with eRF1 (and
eRF3), but not the PoTC formed by PUR (13). Since
our yeast PoTC was prepared with PUR, we determined
whether PoTC prepared with eRF1 and eRF3 would
behave identically to that prepared with PUR. Because
our substrate was derived from polysomes isolated from
growing yeast, most of the ribosomes on the mRNA do
not have a termination codon at the A-site. Therefore,
eRF1 would not be expected to release the peptide.
However, yeast eRF1 is known to release the peptides
slowly from P-site-bound peptidyl-tRNA without a ter-
mination codon at the A-site in vitro (25). Prokaryotic
release factors (RF1 and RF2) are proposed to hydrolyse
the ester bond of peptidyl-tRNA in vivo even when the
A-site does not have a termination codon in stalled ribo-
somes (26). In accordance with these ﬁndings, Figure 3A
indicates that eRF1/eRF3/GTP ternary complex released
35S-labelled nascent peptides from the polysomes, result-
ing in the model PoTC. eEF3/ATP released 28% of the
mRNA from the PoTC formed by termination factors
(Figure 3B) though the efﬁciency was modest compared
with what we showed previously for PoTC prepared with
PUR (59%) (10). This is probably due to smaller amount
of PoTC when prepared with eRF1/eRF3 as shown in
Figure 3A. We should point out that we never removed
the added eRF1 and eRF3 from the resulting PoTC, sug-
gesting that these factors are still bound to the PoTC as
the case of higher eukaryotes (13). Possible role of eRF1/
eRF3 and eEF3 in the rescue of stalled ribosomes based
on these data is discussed in the Supplementary data. We
further demonstrate the inhibitory effect of CHX on the
mRNA release from that PoTC created by eRF1/eRF3 as
shown in Figure 3C. This ﬁgure indicates that the IC50
(6 mM) of CHX with this substrate was comparable with
IC50 with the PoTC obtained by PUR (compare with IC50
shown in Figure 1H).
Inhibitory effect of LTM on the disassembly of the PoTC
by eEF3/ATP
LTM was recently shown to bind to the CHX-binding site
and inhibited the translocation step (2). As shown in
Figure 4, LTM also inhibited all three reactions of the dis-
assembly equally. The observed IC50 values (15 18 mM)
were about ﬁve times higher than those of CHX, and the
maximum inhibition was obtained at 100 mM. This value is
similar to the concentration (200 mM LTM) which inhibits
translocation almost completely (2). These data, together
with the data shown in the preceding section, suggest that
there is a reaction common to recycling and translocation
despite that they are catalysed by different factors.
Dual effects of PAR: inhibition of PoTC disassembly and
induction of subunit association
Aminoglycosides, such as streptomycin (27) and PAR
(28), are known to inhibit translocation as well as
inducing miscoding (29). Since we found that PAR is a
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potent inhibitor of ribosome recycling (10,30), we
investigated this compound further to gain insights into
the mechanism of the recycling in yeast. As shown in
Figure 5, PAR has dual actions. PAR inhibited all three
reactions of the disassembly process (Figure 5A–C).
In addition, it re-associated yeast ribosomal subunits
(Figure 5D) as it did the bacterial ribosomal subunits
(31). This suggested that it acts like Mg2+, but this was
disproven by the experiment shown in Figure 5E,
demonstrating that the inhibitory effect of PAR on the
disassembly reaction was not signiﬁcantly inﬂuenced by
Mg2+. These data imply that PAR inhibits ribosome
recycling not by its association activity of ribosomal
subunits but by some other mechanism(s). In contrast,
Mg2+ has a remarkable stimulatory effect on the inhib-
ition by CHX. Signiﬁcance of these observations will be
described in the discussion section.
CHX or PAR inhibits the ATP hydrolysis and the
disassembly reaction
The eEF3-dependent disassembly of PoTC requires ATP
(10), but how the ATP energy is used for the disassembly
reaction remains obscure. As shown in Figure 6, 20% of
the ATP hydrolysis by eEF3/ribosomes was inhibited by
CHX or PAR at a high antibiotic concentration (1mM).
At this concentration, CHX or PAR gives almost
complete maximum inhibition of eEF3-dependent disas-
sembly reaction (Figure 1G–I and 5A–C). The amount of
ATP hydrolysis (97 pmol) accompanying the recycling is
far greater than the molar amount of the recycled PoTC
(1.5 pmol). The amount of ATPase inhibited (22 pmol)
was also far greater than the amount of recycled PoTC.
We could not estimate how many molecules of ATP hy-
drolysis were necessary for the recycling of one molecule
BA
C
D E
F
Figure 2. CHX is a non-competitive inhibitor of both eEF3 and ATP. (A and D) Lineweaver–Burk plots of the disassembly reaction (mRNA
release) inhibited by CHX at various concentrations of eEF3 (A) or ATP (D). (B and C) The slope (B) or Y intercept (C) of A was plotted against
the concentrations of CHX. Ki and Ki’ of CHX were estimated to be 34 mM and 33 mM from B and C, respectively, where Ki and Ki’ are the
dissociation constants for the enzyme–inhibitor (EI) complex or the enzyme–substrate–inhibitor (ESI) complex, respectively. (E and F) The slope
(E) or Y intercept (F) of D was plotted against the concentrations of CHX. Ki and Ki’ of CHX were estimated to be 35 mM and 33 mM from E and
F, respectively.
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of PoTC. We can conclude, however, that the recycling
inhibitors inhibit both recycling and ATP hydrolysis, con-
sistent with the notion that ATP hydrolysis is necessary
for the recycling. On the other hand, vanadate, an ATPase
inhibitor (32), inhibited ATP hydrolysis by eEF3/ribo-
somes about 50% (52 pmol) without inhibiting the disas-
sembly of PoTC (10), suggesting that the ATP energy
consumption with eEF3 consists of two parts, one import-
ant for the disassembly of PoTC (vanadate-insensitive
and CHX-sensitive) and the other not important
(vanadate-sensitive and CHX-insensitive).
eEF2/GTP/SOR or eEF2/GTP/FA inhibits ribosome
splitting but not release of tRNA or mRNA
Next, we explored the effect of SOR and FA, which are
well-known translocation inhibitors in yeast, but only
slightly inhibit the eEF3-dependent release of mRNA
from PoTC (10). To our surprise, however, upon combin-
ation with eEF2 and GTP, these translocation inhibitors
preferentially inhibited the splitting of ribosomes, with
much less inhibition of the two other reactions, the
release of tRNA and mRNA (Table 1, details of experi-
mental conditions are described below).
A
B
C
Figure 3. PoTC created by eRF1 and eRF3 is disassembled by eEF3. This reaction is also sensitive to CHX. (A) eRF1/eRF3/GTP releases
35S-labelled nascent peptides from the polysomes. The complete reaction mixture (60 ml) contained 20 pmol of labelled polysomes, 30 pmol of
eRF1, 30 pmol of eRF3 and 20 nmol of GTP. Components of each reaction tube are as indicated in the inset. The reaction was carried out at
30C and stopped by 1mM anisomycin at the indicated times. The mixture was subjected to SDGC, and the radioactivity remaining on the
polysomes was counted. (B) eEF3/ATP disassembles the PoTC formed by eRFs/GTP. Non-labelled polysomes were incubated with eRFs/GTP
for 30min to release peptide as in A. eEF3/ATP was then added, incubated for 3min at 30C to disassemble the formed PoTC. The reaction was
stopped by 25mM MgCl2, which also converts formed subunits to 80S ribosomes. The percentage of mRNA release was estimated from the
reduction of the polysome and is indicated above the polysome region. Note the decrease (28% less) in polysome area and the increase of 80S
peak between the extreme left and right panels (arrows). (C) CHX inhibits the disassembly of the PoTC formed by eRFs/GTP. Experimental
conditions were as in B, except that various amounts of CHX were added just before the disassembly reaction, which was carried out for 1min.
Inhibitory effect of CHX (percent inhibition of mRNA release) is plotted against concentration of CHX.
A B C
Figure 4. Inhibitory effect of LTM on the disassembly of the PoTC by eEF3/ATP. The experimental conditions are the same as in Figure 1 except
that various concentrations of LTM were added. Transfer RNA release (A) and mRNA release (B) from the PoTC and the ribosome splitting of the
PoTC (C) are shown.
270 Nucleic Acids Research, 2013, Vol. 41, No. 1
 at Thom
as Jefferson U
niversity, Scott Library on January 23, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
In Figure 7, we analysed the ribosome splitting of PoTC
by eEF3 and ATP. It is clear that the major reaction prod-
ucts were 40S and 60S subunits (Figure 7B). When the re-
action was carried out in the presence of eEF2/GTP/SOR,
the major products were 80S ribosomes (Figure 7D),
showing that the splitting was preferentially inhibited.
Similar results were obtained with eEF2/GTP/FA
(Figure 7G). Other panels indicate that these three com-
ponents (eEF2/GTP/SOR or eEF2/GTP/FA) are essential
to produce signiﬁcant accumulation of 80S ribosomes. As
shown in Table 1, in contrast to the clear-cut inhibition of
the subunits formation, the release of tRNA measured by
the amount of 14C-aminoacyl tRNA formed was not sig-
niﬁcantly inhibited (Supplementary Table S1). Similarly,
the release of mRNA measured by the decrease of the
polysome was not signiﬁcantly inhibited (Figure 8,
compare C with D or with E). These results show that
the inhibitory effect is speciﬁc on the ribosome splitting.
However, the data described above could mean that, in
the presence of inhibitor complexes, 80S ribosomes were
released from PoTC as such or that re-association of the
subunits occurred after the ribosomes of PoTC were split
by eEF3/ATP. The latter possibility was ruled out by the
inability of the inhibitor complexes to produce 80S ribo-
somes when added after the completion of the splitting
reaction (Figure 7J). We conclude that eEF2/GTP/FA
does not stimulate re-association of split subunits but
keeps subunits together on the PoTC and allows the
release of mRNA. To substantiate this conclusion
further, the eEF3/ATP-dependent reaction on PoTC was
performed in the presence of added 32P-labelled 60S
subunits (Figure 8F and G). It is clear that an insigniﬁcant
portion of 32P-labelled 60S subunits was converted into
32P-80S ribosomes. This reveals that the 80S ribosomes
A B C
D E
Figure 5. Dual effects of PAR. (A–C) Inhibition of PoTC disassembly. The experimental conditions are the same as in Figure 1 except that various
concentrations of PAR were added. (D) Induction of subunit association by PAR. PoTC was disassembled into subunits by eEF3/ATP (left panel).
The disassembled ribosomes were further incubated for 5 s at 30C without PAR (middle panel) while the mixture shown in the right panel was
incubated with 1mM PAR for 5 s at 30C. Then, the mixtures were subjected to SDGC, and sedimentation behaviours of the ribosomes are shown.
(E) Effect of Mg2+ on the inhibitory effect of CHX and PAR. The disassembly of PoTC was carried out as in Figure 1, except that the reaction
mixture contained 100mM CHX (m) or PAR (#) and various concentrations of MgCl2 as indicated. The percent inhibition was calculated from the
extent of the release of mRNA with antibiotic compared with that without antibiotic at each concentration of MgCl2.
Figure 6. Effects of CHX or PAR on ATP hydrolysis during the
eEF3-catalysed disassembly of PoTC. The reaction mixture (15 ml) con-
tained 0.1 mM PoTC, 0.5 mM eEF3, 50 mM [g-32P]ATP, and various
concentrations of inhibitors in buffer 3/150. Incubation was carried
out at 30C for 1min, and the hydrolysis of ATP was plotted against
the concentrations of inhibitors. Vanadate [an inhibitor of ATPase (32)]
is a positive control and indicates the partial inhibition of the ATPase
of eEF3/ribosome.
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A B C
D E F
G H I J
Figure 7. eEF2/GTP/SOR or eEF2/GTP/FA speciﬁcally inhibits eEF3/ATP-dependent splitting of 80S ribosomes of the PoTC. Sedimentation
proﬁles of ribosomes after the disassembly reaction of PoTC by eEF3/ATP under various conditions are shown. Final concentrations of each
component are as follows: 50 mM ATP, 0.5 mM eEF3, 1mM PUR, 0.5 mM eEF2, 10 mM GTP, 100 mM SOR, 1mM FA. An inhibitor mix (i.e. eEF2/
GTP/SOR or eEF2/GTP/FA) was added before the disassembly reaction unless otherwise indicated. The reaction was stopped at 1min by formal-
dehyde and centrifuged through 5–30% SDGC as in Figure 1D–F. (A) Only ATP/PUR was added. These ribosomal peaks represent background
values. (B) Complete disassembly reaction. Note the increase of subunits. (C) Lack of effect of eEF2/GTP alone. (D) Complete reaction with
inhibitor mix (eEF2/GTP/SOR). Note the increase of 80S peak and the decrease of subunits. (E) D without GTP. (F) D without eEF2. (G), (H) and
(I) correspond to D, E and F, respectively, except that FA was added instead of SOR. Note the large peak of 80 S in D and G (arrows), presumably
the complex with eEF2/inhibitors. (J) corresponds to G except that eEF2/GTP/FA was added after disassembly into subunits took place (1min).
Note that no increase of 80S ribosome was observed in this case.
Table 1. eEF2/GTP/SOR or eEF2/GTP/FA preferentially inhibits ribosome splitting by eEF3/ATP
Compound added Release of Ribosome splitting
tRNA, cpm Inhibition, % mRNA, % Inhibition, % Splitting, AU Inhibition, %
None 693 0 40 0 1488 0
eEF2/GTP/SOR 535 23 31 22 109 93
eEF2/GTP/FA 570 18 36 11 41 97
The reaction mixture and experimental conditions were as in Figure 1 without CHX, except for the presence of eEF2/GTP/SOR or eEF2/GTP/FA
where indicated. Percentages of mRNA release (z) were calculated: z=100 (1 y/w), where (y) is the polysome area remaining after the reaction
and (w) is that without any factors.
Ribosome splitting was calculated as follows. Splitting (arbitrary units, AU)= (area of subunits after the reaction) (initial area of subunits). The
percent inhibition was calculated from the extent of the reaction with inhibitor mix compared with that without inhibitor mix.
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observed in Figure 7D and G or Figure 8D and E were not
formed after the ribosomes of PoTC were split into
subunits. As a control, we established that the
32P-labelled 60S subunits used in the experiment were
capable of forming 80S ribosomes with the 40S subunits
under identical ionic conditions but in the presence of
PAR, which is found to associate subunits
(Supplementary Figure S1). We thus conclude that
eEF2/GTP/SOR or FA preferentially inhibited the
ribosome splitting reaction by eEF3/ATP.
DISCUSSION
Based on these results, known characteristics of the inhibi-
tors used in this study and an analogy to the ribosome
recycling steps in E. coli, we propose the sequential steps
of the ribosome recycling by eEF3 and ATP as shown in
Figure 9A–E. The substrate for eEF3/ATP is PoTC with
deacylated tRNA at the P/E site (complex A), which is in
equilibrium with PoTC with deacylated tRNA at P/P site
(complex F) (33–35). It has been suggested that CHX
prevents translocation by ﬁxing tRNA at the E-site (36)
while LTM inhibits translocation by binding to the E-site,
which prevents tRNA from coming to the E-site (2). On
these bases, we propose that CHX and LTM inhibit dis-
assembly of PoTC by not allowing tRNA to be released
from the E-site (complex G and H). We suggest that eEF3
moves tRNA from P/E site to E/E site (complex A to B)
and releases tRNA from the ribosomal E site (complex B
to C). This is consistent with our observation that the
inhibitory effect of CHX on the disassembly reaction
was enhanced at high Mg2+ concentration (Figure 5E).
This is probably because Mg2+ increases the afﬁnity of
deacylated tRNA to the E site (37) and ﬁts well with the
hypothesis that CHX traps tRNA on the E site of the
ribosomes (36). We propose that tRNA is released from
PoTC ﬁrst as suggested from the ribosome recycling in
E. coli (30). CHX and LTM prevent this ﬁrst step by
two different mechanisms as mentioned above (Figure 1G
and 4A) (Figure 9, complexes A through C). It has been
shown that PAR prevents the exchange of P-site-bound
tRNA with free tRNA (38). The binding site of PAR on
the large subunit overlaps with the P-site (39). Recently,
other aminoglycoside kanamycin (2-deoxystreptamine-like
PAR) was shown to stabilize P/P-site-bound tRNA (40).
These ﬁndings are consistent with the possibility that PAR
ﬁxes tRNA on the P-site (Figure 9, complex I), resulting in
the inhibition of tRNA release (Figure 5A).
After PoTC loses tRNA, the stability of bound mRNA
is signiﬁcantly weakened (41), causing mRNA release
(Figure 9, complex C to D). We should hasten to add
that this does not necessarily mean that the release of
mRNA is spontaneous after the release of tRNA. Since
the inhibition of ribosome splitting by eEF2/GTP/SOR or
A B C D E
F G
Figure 8. eEF2/GTP/SOR or eEF2/GTP/FA inhibits ribosome splitting but not release of mRNA. (A–E) eEF3/ATP releases 80S ribosomes from
the PoTC in the presence of eEF2/GTP/SOR or FA. (A) No additions. (B) ATP/PUR was added. (C) Complete reaction mix for disassembly.
(D) Inhibitor mix (eEF2/GTP/SOR) was added to C. (E) Inhibitor mix (eEF2/GTP/FA) was added to C. Note the large peak of 80S in D and E
(arrows), but the amount of polysomes are about the same for these three conditions. (F and G) Lack of incorporation of externally added labelled
60S subunits into 80S ribosomes formed from PoTC by eEF3/ATP in the presence of eEF2/GTP/SOR or FA. The reaction shown in Table 1 with 15
pmol of PoTC and other components was performed in the presence of 32P-labelled 60S subunits (0.25 pmol) with eEF2/GTP/SOR (F) or FA
(G). The mixture was subjected to 5–30% SDGC, and both UV absorbance and radioactivity were measured for each fraction.
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by eEF2/GTP/FA gave 80S ribosomes rather than
poly-80S without tRNA (Figure 8 and Table 1), we
propose that the ribosome splitting occurs after the
release of mRNA (Figure 9, complex D to E). The order
of events is further supported by the fact that we never
observed polysomes with 40S subunits as an intermediate
during the disassembly reaction by eEF3/ATP (compare
polysome region of Figure 1A with B). The ribosome
splitting is inhibited by eEF2/GTP/SOR or eEF2/GTP/
FA because these complexes would bind to the 80S
ribosome forming complex J shown in Figure 9 (42,43).
Given that eEF2 binds to helix 44 of the 40S subunit (h44)
and to helix 69 of the 60S subunit (H69) (43), it is con-
ceivable that the eEF2/GTP/SOR or FA stabilizes the
subunits’ bridge resulting in the 80S ribosomes (Table
1). PAR induces the association of subunits (Figure 5D)
in addition to the inhibitory effect on the tRNA release as
discussed above. PAR is known to inhibit splitting of 70S
ribosomes in E. coli (31) probably because PAR binds to
h44 and H69 (39). However, in contrast to eEF2/GTP/
SOR or FA, PAR does not inhibit ribosome splitting
without inhibiting tRNA/mRNA release in the disassem-
bly reaction (Figure 5A–C). This is in accordance with the
hypothesis that the complete disassembly by eEF3 must
proceed according to the order described in Figure 9.
Since PAR inhibits the ﬁrst reaction, the effect on any
of the reactions, such as splitting, after the ﬁrst reaction
cannot be seen. The lack of Mg2+ effect on the inhibitory
activity of PAR (Figure 5E) is consistent with this scheme
because Mg2+ stimulates ribosome subunits association.
The stepwise disassembly proposed in this ﬁgure should
be further conﬁrmed using fast kinetics with mRNA of
known sequence.
Regarding the possible role of ABCE1 and eEF3 in
yeast ribosome recycling in vivo, ABCE1 (44,45) and
eEF3 mutants (6) are of interest. The in vivo inactivation
of ABCE1 resulted in accumulation of monosomes (44,46)
and reduction of 40S-bound eIF1 and eIF2 (44). On this
basis, the authors suggested that ABCE1 may function in
the initiation process. In addition, inactivation of ABCE1
caused read-through of the termination codon, leading the
authors to conclude that it functions in the termination
process (45). Recent in vitro experiments suggest that
ABCE1 is involved in the termination process (11). In
contrast, when eEF3 is inactivated in vivo, polysomes ac-
cumulate (6). Since eEF3 was believed to be necessary only
for the elongation process before our ﬁnding (10), this was
interpreted as a result of the halt of the ribosomes during
the peptide chain elongation. However, in vivo inactiva-
tion of eEF1A (which is known to be involved in the
elongation only) gave much less accumulation of
polysome compared with that accumulated upon inactiva-
tion of eEF3 [Figure 3 of (6)]. These observations strongly
suggest that the conspicuous accumulation of polysomes
upon in vivo loss of eEF3 function is mostly the result of
inactivation of the recycling activity of eEF3. It is under-
standable that inhibition of the release of ribosomes from
mRNA at the termination site leaves more ribosomes on
the mRNA, causing the increase of polysomes. Taken
together, we suggest that eEF3, rather than ABCE1,
may play the major role for the ribosome recycling step
at the end of most of ORF in yeast. Since eEF3 is involved
in the peptide chain elongation by removing the
E-site-bound tRNA, this suggestion is consistent with
the present ﬁnding that there is common mechanism
between elongation and recycling in yeast. We further
propose that the recycling mechanism involving ABCE1
described for Archaea and mammals, and thus pre-
sumably primordial, has been supplanted in yeast with
an eEF3-catalysed reaction, even though ABCE1 is
conserved and essential in yeast. The reason why
ABCE1 is essential for yeast may be because it is
E
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Figure 9. Proposed steps of the eEF3/ATP-dependent complete disassembly of PoTC. A and F are in equilibrium. A through E show the stepwise
disassembly of PoTC (in the area coloured with pale grey). G through J show the presumed complexes of PoTC or partially disassembled PoTC with
the inhibitors.
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important for initiation, termination and other functions
such as ribosome biogenesis (47), but may not be due to its
possible function in ribosome recycling.
We are aware of the possibility that the use of model
PoTC that does not have a termination codon at the A-site
may invalidate our conclusions in this article.
Furthermore, most of our model PoTC was created by
PUR instead of eRF1 and eRF3. However, we justify
the use of model PoTC because this led us to the discovery
of ribosome recycling factor (RRF) which is recognized to
recycle ribosomes in prokaryotes (48,49). In addition,
everything discovered with the model PoTC was con-
ﬁrmed by the in vitro experiments using naturally
occurring ORF which harbours seven codons (50–53).
Moreover, these in vitro results are consistent with the
results of in vivo experiments (54,55). In this article,
some of PoTC was prepared with eRF1 and eRF3
rather than with PUR. They gave similar results as those
prepared with PUR. No in vitro ribosome recycling with
long ORF has been reported. Studies are currently in
progress to achieve in vitro disassembly of natural PoTC
with long mRNA in yeast. Further evidence that LTM
binds to the E site as shown in Figure 9 has recently
been published in (56).
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